Delivery Order SPE2DR25D3505-SPE2DR26F94D4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,047.90 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Varivax vaccine with diluents. This competitively awarded, non-set-aside contract carries a ceiling value of $14,991.90 and is structured as a firm fixed-price delivery order with a completion date of December 24, 2025. The vaccines will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Varivax vaccine with diluents, valued at $7,935.60 with a firm fixed price structure. The contract, which is classified as a child award under a larger indefinite delivery vehicle, has an ultimate completion date of January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Varivax vaccine with diluents. This $19,839 firm fixed price delivery order is scheduled for completion by December 31, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through the company's existing contract vehicle. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents under a firm fixed price contract valued at $4,489.92. The delivery order, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, represents a non-competitive award to support federal medical supply needs. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $1,052.96 and an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, issued under a non-set-aside competition, represents a routine pharmaceutical procurement through DLA's medical supply chain. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,098.45 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Varivax vaccine with diluents. This firm fixed price delivery order, valued at $3,158.88, represents a non-competitive award under an existing indefinite delivery contract and is scheduled for completion by August 27, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Varivax vaccine with diluents, valued at $4,048.76. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of December 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $1,019.65 with a completion date of December 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F94D4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $4,038.32. This firm fixed-price delivery order, with an ultimate completion date of December 22, 2025, represents a non-competitive award placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location, fulfilling critical pharmaceutical supply requirements for the Department of Defense's medical support chain. This delivery order is issued as a child contract under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant role in the Defense Health Agency's medical supply chain, leveraging its extensive inventory and distribution capabilities to meet federal healthcare requirements across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/30/25 |